Methods, compositions, and compounds for allosteric modulation o

Details Methods, compositions, and compounds for allosteric modulation o Methods, compositions, and compounds for allosteric modulation o

1993-08-02

1997-01-07

Tsang, Cecilia

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

552505, 552540, 552541, 552542, 552544, 552546, 552547, 514169, 514176, 514177, 514178, 514179, 514180, 514181, 514182, 540 36, 540 94, 540 95, 540 96, 540 97, 540 98, 540 99, 540106, 540107, 540108, 540109, 540110, 540111, 540112, 540114, 540116, 540120, C07J 900, C07J 2100, C07J 4300, A61K 3158, A61K 3156

Patent

active

055917330

ABSTRACT:
Method, compositions, and compounds for modulating brain excitability to alleviate stress, anxiety, insomnia and seizure activity using certain steroid derivatives that act at a newly identified site on the gamma-aminobutyric acid receptor-chloride ionophore (GR) complex.

REFERENCES:
patent: 2306635 (1942-12-01), Marker
patent: 3061606 (1962-10-01), Gut et al.
patent: 3132160 (1964-05-01), Wechter
patent: 3139445 (1964-06-01), Wiechert et al.
patent: 3214427 (1965-10-01), Ercoli et al.
patent: 3385849 (1968-05-01), Krubiner et al.
patent: 3494943 (1970-02-01), Krsek
patent: 3636011 (1972-01-01), Phillipps et al.
patent: 3637670 (1972-01-01), Fried
patent: 3647829 (1972-03-01), Kruger
patent: 3665021 (1972-05-01), Elks et al.
patent: 3726864 (1973-04-01), Phillipps et al.
patent: 3763195 (1973-10-01), Davis et al.
patent: 3816624 (1974-06-01), Davis et al.
patent: 3822297 (1974-07-01), Phillipps et al.
patent: 3822298 (1974-07-01), Clayton et al.
patent: 3825565 (1974-07-01), Gregory et al.
patent: 3869451 (1975-03-01), Phillipps et al.
patent: 3875148 (1975-04-01), Elks et al.
patent: 3882151 (1975-05-01), Phillipps et al.
patent: 3900561 (1975-08-01), Davis et al.
patent: 3943124 (1976-03-01), Phillipps et al.
patent: 3953429 (1976-04-01), Cook et al.
patent: 3959260 (1976-05-01), Phillipps et al.
patent: 3969345 (1976-07-01), Phillipps et al.
patent: 3983111 (1976-09-01), Phillipps et al.
patent: 3989686 (1976-11-01), Phillipps et al.
patent: 3998829 (1976-12-01), Phillipps et al.
patent: 4029777 (1977-06-01), Engelfried et al.
patent: 4061661 (1977-12-01), Kerb et al.
patent: 4192871 (1980-03-01), Phillipps et al.
patent: 4197296 (1980-04-01), Phillipps et al.
patent: 4213978 (1980-07-01), Bodor et al.
patent: 4360470 (1982-11-01), Batcho et al.
patent: 4424218 (1984-01-01), Deraedt et al.
patent: 5120723 (1992-06-01), Gee et al.
patent: 5208227 (1993-05-01), Gee et al.
patent: 5232917 (1993-08-01), Bolger et al.
patent: 5371077 (1994-12-01), Schroepfer, Jr. et al.
Aird, R. B. and Gordan, G. S., "Anticonvulsive Properties of Desoxycorticosterone," J. Amer. Med. Assoc. 145(10):715-719 (1951).
Arafat et al., "Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites," Am. J. Obstet. Gynecol. 159(5):1203-1209 (1988).
Atkinson et al., "Action of Some Steroids on the Central Nervous System of the Mouse," J. Med. Chem. 8:426-432 (1965).
Backstrom et al., "Endocrinological Aspects of Cyclical Mood Changes During the Menstrual Cycle or the Premenstrual Syndrome," J. Psychosom. Obstet. Gynaecol. 2:8-20 (1983).
Backstrom et al., "Ovarian Steroid Hormones. Effects on Mood, Behaviour and Brain Excitability," Acta Obstet. Gynecol. Scand. Suppl. 130:19-24 (1985).
Barker et al., "Potentiation of .UPSILON.-Aminobutyric-Acid-Activated Chloride Conductance by a Steroid Anaesthetic in Cultured Rat Spinal Neurones," J. Physiol. 386:485-501 (1987).
Barnes, D. M., "Steroids May Influence Changes in Mood," Science 232:1344-1345 (1986).
Barton et al., "Constitution of limonin and related bitter principles," Chem. Abstracts 55:11458d-11461c (1961).
Belelli et al., "Anticonvulsant Profile of the Progesterone Metabolite 5-.alpha.-pregnan-3-.alpha.-ol-20-one," Eur. J. Pharmacol. 166(2):325-329 (1989).
Blumstein et al., "Further Characterization of a Simple, Automated Exploratory Model for the Anxiolytic Effects of Benzodiazepines," Pharmacol. Biochem. Behav. 18:37-40 (1983).
Bodor, N., "Novel Approaches in Pro Drug Design," Drugs of the Future 6(3):165-182 (1981).
Bruhwyler, J., "Anxiolytic Potential of a Microgram Dose of Chlordiazepoxide in the Open-field Test," Eur. J. Pharmacol. 187:547-549 (1990).
Bruhwyler et al., "Anxiolytic Potential o Sulpiride, Clozapine and Derivatives in the Open-field Test," Pharmacol. Biochem. Behav. 36(1):57-61 (1990.
Bundgaard, H., Design of Prodrugs, H. Bundgaard, ed., Elsevier, N.Y. (1985).
Bush, I.E. and Mahesh, V.B., "Metabolism of 9.alpha.--Fluorocortisone and 9.alpha.--Fluorocortisol," Biochem. J. 69:9P--10P (1958).
Callachan et al, "Modulation of the GABA.sub.A receptor by progesterone metabolites," Proc. R. Soc. Lond. B 231:359-369 (1987).
Chemical Abstracts, STN File CA, Abstract for German Patent No. 2218413, Anner et al. "6.alpha., 9.alpha.--Difluoro--16.alpha.--methyl--11.beta., 17.alpha.--dihydroxy--3.beta.--acetoxy--20--oxopregn--4--ene" (Nov. 9, 1972).
Chemical Abstracts, STN File CA, Abstract for European Patent Appl. No. 0 030 368, Schulze et al., "11--Keto Steroids" (Aug. 17, 1981).
Chemical Abstracts, STN File CA, Abstract for German Patent No. 2162555, Cook et al., "3.alpha.-Hydroxy-5.alpha.-pregnan-20-one derivatives" (Jun. 22, 1972).
Chin et al., "Status epilepticus controlled by althesin infusion," Anaesth. Intensive Care 7(1):50-52 (1979).
Christmas et al., "A Comparison of the Effects of Some Benzodiazepines and Other Drugs on Aggressive and Exploratory Behaviour in Mice and Rats," Neuropharmacology 9:17-29 (1970).
Craig, C. R., "Anticonvulsant Activity of Steroids: Separability of Anticonvulsant from Hormonal Effects," J. Pharmacol. Exp. Ther. 153 (2):337-343 (1966).
Craig, C. R. and Deason, J. R., "Anticonvulsant Activity of Steroids, Specificity of Structure," Arch. int. Pharmacodyn. 172 (2):366-372 (1968).
Crawley, J. N., "Neuropharmacologic Specificity of a Simple Animal Model for the Behavioral Actions of Benzodiazepines," Pharmacol. Biochem. Behav. 15:695-699 (1981).
Crawley, J. N. and Davis, L. G., "Baseline Exploratory Activity Predicts Anxiolytic Responsiveness to Diazepam in Five Mouse Strains," Brain Res. Bull. 8:609-612 (1982).
Crawley, J. N. and Goodwin. F. K., "Preliminary Report of a Simple Animal Behavior Model for the Anxiolytic Effects of Benzodiazepines," Pharmacol. Biochem. Behav. 13 (2):167-170 (1980).
Crawley et al., "Absence of Intrinsic Antagonist Actions of Benzodiazepine Antagonists on an Exploratory Model of Anziety in the Mouse," Neuropharmacology 23:531-537 (1984).
Crawley et al., "Annxiolytic Activity of an Endogenous Adrenal Steroid," Brain Res. 398:382-385 (1986).
Czira, G. and Kecskes, L., "Identification and Quantitation of 3.alpha., 21-dihydroxy-5.alpha.-pregn-9 (11)-en--20--one, An Artifact of Allotetrahydrocorticosterone in Acid--hydrolysed Urine of Children," Proc. of the Symp. on the Analysis of Steroids, S. Gorog, ed., Szeged, Hungary, pp. 421-427 (Jun. 12-14, 1984).
Dalton, K., in: Premenstrual Syndrome and Progesterone Therapy, 2nd ed., Chicago, Chicago yearbook (1984).
Davies, C. and Steinberg, H., "A Biphasic Effect of Chlordiazepoxide on Animal Locomotor Activity," Neurosci. Lett. 46:347-351 (1984).
De Riu et al., "Anticonvulsant Activity of Althesin on Experimental Epilepsy," Br. J. Anaesth. 54:343-347 (1982).
Dennerstein et al., "Progesterone and the Premenstrual Syndrome: A Double Blind Crossover Trial," British Med. J. 290:1617-1621 (1985).
Eimasry, A. H. and Gisvold, O., "19--Norsteroids of Unnatural Configuration from Ergosterol," J. Pharm. Sci. 59 (4):449-458 (1970).
Eneroth et al., "Excretion and Anticonvulsant Activity of Steroid Hormones in an Infant with Infantile Spasm and Hypsarrhytmia Treated with Excessive Doses of ACTH", J. Steroid Biochem. 3:877-887 (1972).
Fieser, L. F. and Fieser, M., in: Steroids, Reinhold Publ. Corp., N.Y., pp. 566, 573, 575 and 614 (1959).
File, S. E., "The Use of Social Interaction as a Method for Detecting Anxiolytic Acitivty of Chlordiazepoxide-like Drugs," J. Neurosci. Meth. 2;219-238 (1980).
Gee, K. W. and Yamamura, H. I., "Benzodiazepines and Barbituates: Drugs for the Treatment of Anxiety Insomnia, and Seizure Disorders," in: Drugs in Central Nervous System Disrorders, D. C. Horwell, ed., pp. 123-147.
Gee et al., "GABA-Dependent Modulation of the Cl.sup.- Ionophore by Steroids in Rat Brain," Eur. J. Pharmacol. 136:419-423 (1987).
Gee et al., "Modulation of the Chloride Ionophore by Benzodiazepine Receptor Ligands: Influence of Gamma-aminobutyric Acid and Ligand Efficacy," Molec. Pharmacol. 30:218-225 (1986).
Geller et al., "The Effects of Chlordiazepoxide and Chlorpromazine on a Punishment D

Affiliated with

Also associated with

Rating

Methods, compositions, and compounds for allosteric modulation o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods, compositions, and compounds for allosteric modulation o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods, compositions, and compounds for allosteric modulation o will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1764284